Gene therapy plus angioplasty for severe leg blockages
Part of Heart & circulation clinical trials.
This study tests if adding gene therapy to a standard leg artery-opening procedure (angioplasty or stenting) helps people with severe leg pain or non-healing wounds due to blocked arteries. It may improve blood flow and save the leg from amputation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a blocked artery in your leg causing severe pain at rest or a non-healing sore
- You have not had any surgery on that leg before
- You are not pregnant or breastfeeding
- You are not currently on chemotherapy or radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to restore blood flow in the lower leg for people with chronic limb-threatening ischemia, a serious condition where leg wounds won't heal due to poor circulation. If it works, this treatment could help save the leg and avoid amputation.
This study tests a new way to restore blood flow to the leg in people who have wounds or dead tissue on their foot and have run out of other treatment options. It's for those who have already tried angioplasty twice without success or have severely hardened small arteries.
This trial tests whether an experimental injection called seltoplasmid, given along with a procedure to restore blood flow in the leg (revascularization), can help heal diabetic foot ulcers that have not responded to standard care. It is designed for people with severe leg artery blockages that threaten the limb.
This study tests a special balloon to open blocked arteries below the knee in people with severe leg pain or wounds. It aims to improve blood flow and save the limb from amputation.
This study is testing a new drug-coated stent for blocked arteries in the thigh or behind the knee. It may help people with moderate to severe leg pain or wounds by improving blood flow without needing surgery.
This study follows up with people who previously took part in a clinical trial testing an experimental gene therapy for critical limb ischemia (severe leg pain or sores due to blocked arteries). It aims to see how well the treatment works over time. If you were in that earlier trial and received at least one dose, joining this follow-up could help researchers learn more about the therapy's lasting effects.
Hear when a new Severe Lower Limb Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.